Home/Filings/4/0001209191-23-023690
4//SEC Filing

Gandhi Leena 4

Accession 0001209191-23-023690

CIK 0001538210other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 8:43 PM ET

Size

10.0 KB

Accession

0001209191-23-023690

Insider Transaction Report

Form 4
Period: 2023-04-04
Gandhi Leena
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-04-0480,9470 total
    Exercise: $3.07Exp: 2032-05-05Common Stock (80,947 underlying)
  • Award

    Stock Option (right to buy)

    2023-04-04+35,97635,976 total
    Exercise: $1.64Exp: 2032-05-05Common Stock (35,976 underlying)
  • Award

    Stock Option (right to buy)

    2023-04-04+44,97144,971 total
    Exercise: $1.23Exp: 2032-05-05Common Stock (44,971 underlying)
Footnotes (1)
  • [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 5, 2022, of which 24,733 shares vested, and the remainder of the options will vest in equal monthly installments such that on May 5, 2025, all shares subject to the option shall be vested, subject to Ms. Gandhi's continued service on each vesting date.

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1
  • filerCIK 0001927002

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:43 PM ET
Size
10.0 KB